Editorial: Defining the Spatial Organization of Immune Responses to Cancer and Viruses In Situ

por Phillips, Darci, Rodig, Scott J., Jiang, Sizun
Publicado 2022

Sphingosine-1-Phosphate Receptor 1 in Classical Hodgkin Lymphoma: Assessment of Expression and Role in Cell Migration

por Kluk, Michael J., Ryan, Kieran, Wang, Bonnie, Zhang, Guoqi, Rodig, Scott J., Sanchez, Teresa
Publicado 2013

NF-κB-regulated VentX expression mediates tumoricidal effects of chemotherapeutics at noncytotoxic concentrations

por Le, Yi, Gao, Hong, Zhu, Angie, Felt, Kristen, Rodig, Scott, Bleday, Ronald, Zhu, Zhenglun
Publicado 2022

Effect of treatment with a JAK2-selective inhibitor, fedratinib, on bone marrow fibrosis in patients with myelofibrosis

por Jamieson, Catriona, Hasserjian, Robert, Gotlib, Jason, Cortes, Jorge, Stone, Richard, Talpaz, Moshe, Thiele, Jürgen, Rodig, Scott, Pozdnyakova, Olga
Publicado 2015

Diffuse large B-cell lymphomas have spatially defined, tumor immune microenvironments revealed by high-parameter imaging

por Wright, Kyle T., Weirather, Jason L., Jiang, Sizun, Kao, Katrina Z., Sigal, Yari, Giobbie-Hurder, Anita, Shipp, Margaret A., Rodig, Scott J.
Publicado 2023

Anti-CTLA-4 based therapy elicits humoral immunity to galectin-3 in patients with metastatic melanoma

por Wu, Xinqi, Giobbie-Hurder, Anita, Connolly, Erin M., Li, Jingjing, Liao, Xiaoyun, Severgnini, Mariano, Zhou, Jun, Rodig, Scott, Hodi, F. Stephen
Publicado 2018

Increased SYK activity is associated with unfavorable outcome among patients with acute myeloid leukemia

por Boros, Katalin, Puissant, Alexandre, Back, Morgan, Alexe, Gabriela, Bassil, Christopher F., Sinha, Papiya, Tholouli, Eleni, Stegmaier, Kimberly, Byers, Richard J., Rodig, Scott J.
Publicado 2015

Immunohistochemical Detection of MYC-driven Diffuse Large B-Cell Lymphomas

por Kluk, Michael J., Chapuy, Bjoern, Sinha, Papiya, Roy, Alyssa, Cin, Paola Dal, Neuberg, Donna S., Monti, Stefano, Pinkus, Geraldine S., Shipp, Margaret A., Rodig, Scott J.
Publicado 2012

Brief Communication on Pathologic Assessment of Persistent Stable Metastatic Lesions in Patients Treated With Anti-CTLA-4 or Anti-CTLA-4 + Anti-PD-1 Therapy

por Buchbinder, Elizabeth I., Pfaff, Kathleen L., Turner, Madison M., Manos, Michael, Ouyang, Olivia, Ott, Patrick A., Giobbie-Hurder, Anita, Rodig, Scott J., Hodi, F. Stephen
Publicado 2023

MYC is essential for the formation and maintenance of germinal centers

por Calado, Dinis Pedro, Sasaki, Yoshiteru, Godinho, Susana A., Pellerin, Alex, Köchert, Karl, Sleckman, Barry P., de Alborán, Ignacio Moreno, Janz, Martin, Rodig, Scott, Rajewsky, Klaus
Publicado 2012

Immunologic profiling of adenoid cystic carcinoma (acc)

por Sridharan, Vishwajith, Liao, Xiaoyun, Chau, Nicole G, Haddad, Robert, El-Naggar, Adel, Freeman, Gordon J, Hodi, F Stephen, Rodig, Scott J, Dranoff, Glenn, Schoenfeld, Jonathan D
Publicado 2015

A phase I trial of panobinostat (LBH589) in patients with metastatic melanoma

por Ibrahim, Nageatte, Buchbinder, Elizabeth I., Granter, Scott R., Rodig, Scott J., Giobbie‐Hurder, Anita, Becerra, Carla, Tsiaras, Argyro, Gjini, Evisa, Fisher, David E., Hodi, F. Stephen
Publicado 2016

Next-Generation cDNA Screening for Oncogene and Resistance Phenotypes

por Shindoh, Nobuaki, Yoda, Akinori, Yoda, Yuka, Sullivan, Timothy J., Weigert, Oliver, Lane, Andrew A., Kopp, Nadja, Bird, Liat, Rodig, Scott J., Fox, Edward A., Weinstock, David M.
Publicado 2012

Prevalence and predictors of androgen receptor and programmed death-ligand 1 in BRCA1-associated and sporadic triple-negative breast cancer

por Tung, Nadine, Garber, Judy E, Hacker, Michele R, Torous, Vanda, Freeman, Gordon J, Poles, Emily, Rodig, Scott, Alexander, Brian, Lee, Larissa, Collins, Laura C, Schnitt, Stuart J
Publicado 2016

CXCR4 upregulation is an indicator of sensitivity to B-cell receptor/PI3K blockade and a potential resistance mechanism in B-cell receptor-dependent diffuse large B-cell lymphomas

por Chen, Linfeng, Ouyang, Jing, Wienand, Kirsty, Bojarczuk, Kamil, Hao, Yansheng, Chapuy, Bjoern, Neuberg, Donna, Juszczynski, Przemyslaw, Lawton, Lee N., Rodig, Scott J., Monti, Stefano, Shipp, Margaret A.
Publicado 2020

Bevacizumab improves tumor infiltration of mature dendritic cells and effector T-cells in triple-negative breast cancer patients

por Boucher, Yves, Kumar, Ashwin S., Posada, Jessica M., Gjini, Evisa, Pfaff, Kathleen, Lipschitz, Mikel, Lako, Ana, Duda, Dan G., Rodig, Scott J., Hodi, F. Stephen, Jain, Rakesh K.
Publicado 2021

RelA-Induced Interferon Response Negatively Regulates Proliferation

por Kochupurakkal, Bose S., Wang, Zhigang C., Hua, Tony, Culhane, Aedin C., Rodig, Scott J., Rajkovic-Molek, Koraljka, Lazaro, Jean-Bernard, Richardson, Andrea L., Biswas, Debajit K., Iglehart, J. Dirk
Publicado 2015

Disruption of asxl1 results in myeloproliferative neoplasms in zebrafish

por Gjini, Evisa, Jing, Chang-Bin, Nguyen, Ashley T., Reyon, Deepak, Gans, Emma, Kesarsing, Michiel, Peterson, Joshua, Pozdnyakova, Olga, Rodig, Scott J., Mansour, Marc R., Joung, Keith, Look, A. Thomas
Publicado 2019

Comprehensive analyses of tumor immunity: implications for cancer immunotherapy

por Li, Bo, Severson, Eric, Pignon, Jean-Christophe, Zhao, Haoquan, Li, Taiwen, Novak, Jesse, Jiang, Peng, Shen, Hui, Aster, Jon C., Rodig, Scott, Signoretti, Sabina, Liu, Jun S., Liu, X. Shirley
Publicado 2016

Abundant PD-L1 expression in Epstein-Barr Virus-infected gastric cancers

por Derks, Sarah, Liao, Xiaoyun, Chiaravalli, Anna M., Xu, Xinsen, Camargo, M. Constanza, Solcia, Enrico, Sessa, Fausto, Fleitas, Tania, Freeman, Gordon J., Rodig, Scott J., Rabkin, Charles S., Bass, Adam J.
Publicado 2016